NEW YORK (GenomeWeb) – Biocept said today that it has begun a clinical research collaboration with the University of Texas Southwestern Medical Center focused on non-small cell lung cancer.

The company will work with a team led by UT Southwestern researcher Saad Khan to evaluate its Target Selector platform for rapid detection of ALK mutations in patients with NSCLC. Tests will be performed both at baseline and longitudinally to measure treatment response and early signs of resistance.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Mar
08
Sponsored by
Swift Biosciences

This webinar will discuss an optimized protocol for methyl-CpG binding domain sequencing (MBD-seq), which enables comprehensive, adequately powered, and cost-effective large-scale methylome-wide association studies (MWAS) of almost all 28 million CpG sites in the genome.

Mar
13

This webinar will share how clinical genetics labs can integrate cytogenetics and molecular data to assess abnormalities using a single sample on a single workflow platform.

Apr
03

Proximity ligation technology generates multi-dimensional next-generation sequencing data that is proving to solve unmet needs in genomic research.